Niche drugs become victims of their own success as off-label use leads to shortages

With IVIG in short supply, hospitals are left to make tough choices about who receives it. The expensive treatment may be a victim of its own widening use.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>